64656 52-Week Disease Control and Safety With As-Needed Application of Ruxolitinib Cream in Children Aged 2 to 11 Years With Moderate and/or More Extensive Atopic Dermatitis: Subgroup Analysis From the TRuE-AD3 Study Author links open overlay panel Lawrence F. Eichenfield MD ,
Publication/Presentation Date
9-2025
Volume
93
Issue
3
First Page
100
Last Page
100
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine Faculty
Document Type
Article
COinS